Kiniksa projects $980M-$995M 2026 revenue guidance while advancing KPL-387 into Phase III PASTORALE — See source for full details.
$KNSA
Price history, market instrument context, member research, and related headlines in one place.
KNSA key statistics
NasdaqGSUSD
52-week range
$35.2091%$82.94
Latest session $77.72–$79.96Kiniksa Pharmaceuticals International, plc (KNSA) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $78.84, up $0.31 (0.39%) from the previous close of $78.53. It has traded between $77.72 and $79.96 in the latest session. Over the past year it has ranged from $35.20 to $82.94, leaving it in the upper quarter of its 52-week range (91%). Reported volume for the session was 576.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Kiniksa Pharmaceuticals International, plc GAAP EPS of $0.30 beats by $0.01, revenue of $243.6M beats by $17.14M — See source for full details.
Loading $KNSA research…